Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus, Human”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00686075
What this trial is testing

Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants

Who this might be right for
Healthy
MedImmune LLC 1,338
Not applicableUnknownNCT05017519
What this trial is testing

Epidemiology and Household Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus

Who this might be right for
Streptococcus Pneumoniae InfectionRespiratory Syncytial Virus Infections
Mackay Memorial Hospital 240
Not applicableStudy completedNCT02133092
What this trial is testing

A Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory Infections

Who this might be right for
Respiratory Syncytial Virus
Janssen Research & Development, LLC 62
Large-scale testing (Phase 3)Study completedNCT06325657
What this trial is testing

Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants

Who this might be right for
Respiratory Syncytial Virus
Pfizer 681
Early research (Phase 1)Study completedNCT02040831
What this trial is testing

Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 3
Not applicableStudy completedNCT01754428
What this trial is testing

Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
Gilead Sciences 2,432
Not applicableStudy completedNCT00100373
What this trial is testing

RSV Challenge in Healthy Adults

Who this might be right for
Respiratory Infections, AcuteRespiratory Syncytial Virus
National Institute of Allergy and Infectious Diseases (NIAID) 13
Not applicableLooking for participantsNCT06998251
What this trial is testing

In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized With Streptococcus Pneumoniae (Spn)

Who this might be right for
Pneumococcal InfectionsRespiratory Syncytial Virus (RSV) InfectionInfluenza Infection
University Hospital, Geneva 280
Early research (Phase 1)Study completedNCT02558413
What this trial is testing

Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers

Who this might be right for
PharmacokineticsHealthy Volunteers
Biota Pharmaceuticals, Inc. 60
Early research (Phase 1)Active Not RecruitingNCT06564194
What this trial is testing

Evaluate JCXH-108, an mRNA-based Vaccine Against RSV

Who this might be right for
Respiratory Syncytial Virus (RSV)Infectious Disease
Immorna Biotherapeutics, Inc. 75
Not applicableUnknownNCT02519803
What this trial is testing

A Prospective Household Observational Cohort Study of Influenza, Respiratory Syncytial Virus and Other Respiratory Pathogens Community Burden and Transmission Dynamics in South Africa

Who this might be right for
Infective Organism Causing Respiratory Diseaseand Meningitis
National Institute for Communicable Diseases, South Africa 4,500
Not applicableStudy completedNCT04944160
What this trial is testing

Impact of the Covid-19 on Respiratory Syncytial Virus (RSV) Epidemic

Who this might be right for
RSV Infection
Hospices Civils de Lyon 600
Early research (Phase 1)Study completedNCT02419391
What this trial is testing

Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine

Who this might be right for
Respiratory Syncytial Virus Infections
Bavarian Nordic 63
Early research (Phase 1)Study completedNCT06194318
What this trial is testing

First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Vaccination
Clover Biopharmaceuticals AUS Pty 160
Testing effectiveness (Phase 2)WithdrawnNCT03468829
What this trial is testing

Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus Lower Respiratory Tract Infection
Ablynx, a Sanofi company
Early research (Phase 1)Study completedNCT06573281
What this trial is testing

A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 213
Large-scale testing (Phase 3)Study completedNCT05127434
What this trial is testing

Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 36,814
Large-scale testing (Phase 3)Study completedNCT02608502
What this trial is testing

Evaluate the Efficacy of an RSV F Vaccine in Older Adults

Who this might be right for
Respiratory Syncytial Virus (RSV)
Novavax 11,850
Early research (Phase 1)Looking for participantsNCT07764237
What this trial is testing

Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile 2) in Older Healthy Adults

Who this might be right for
Respiratory Syncytial Virus (RSV)Human Metapneuomovirus (hMPV)
ModernaTX, Inc. 375
Early research (Phase 1)Not Yet RecruitingNCT07807449
What this trial is testing

Safety and Preliminary Immunogenicity of Recombinant RSV Vaccine （CHO Cell） in Adults Aged 18 Years and Older

Who this might be right for
Respiratory Syncytial Virus (RSV)
Yikang Biotech (Suzhou) Co., Ltd. 128
Next Page